Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 3873501
[patent_doc_number] => 05728387
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-17
[patent_title] => 'Structural gene of pneumococcal protein'
[patent_app_type] => 1
[patent_app_number] => 8/214164
[patent_app_country] => US
[patent_app_date] => 1994-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 4
[patent_no_of_words] => 4111
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/728/05728387.pdf
[firstpage_image] =>[orig_patent_app_number] => 214164
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/214164 | Structural gene of pneumococcal protein | Mar 16, 1994 | Issued |
Array
(
[id] => 4045290
[patent_doc_number] => 05874533
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'HIV-2 envelope polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/213416
[patent_app_country] => US
[patent_app_date] => 1994-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 9932
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874533.pdf
[firstpage_image] =>[orig_patent_app_number] => 213416
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/213416 | HIV-2 envelope polypeptides | Mar 14, 1994 | Issued |
08/213200 | COMPOSITIONS AND METHODS FOR VACCINES COMPRISING ALPHA-GALACTOSYL EPITOPES | Mar 14, 1994 | Abandoned |
08/207910 | METHOD FOR ENHANCING THE ASSOCIATION OF EXOGENOUS PEPTIDES WITH CLASS I MHC MOLECULES ON THE SURFACE OF ANTIGEN PRESENTING CELLS WITH B-2 MICROGLOBULIN | Mar 6, 1994 | Abandoned |
Array
(
[id] => 3717560
[patent_doc_number] => 05616688
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-01
[patent_title] => 'Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)'
[patent_app_type] => 1
[patent_app_number] => 8/207888
[patent_app_country] => US
[patent_app_date] => 1994-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 15906
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/616/05616688.pdf
[firstpage_image] =>[orig_patent_app_number] => 207888
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/207888 | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Mar 6, 1994 | Issued |
08/200744 | THERAPEUTIC PREVENTIVE VACCINES FOR HIV | Feb 22, 1994 | Abandoned |
Array
(
[id] => 3700171
[patent_doc_number] => 05674705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Productive of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies'
[patent_app_type] => 1
[patent_app_number] => 8/194818
[patent_app_country] => US
[patent_app_date] => 1994-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2200
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674705.pdf
[firstpage_image] =>[orig_patent_app_number] => 194818
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/194818 | Productive of human T-cell leukemia (lymphotropic) retrovirus (HTLV-1) envelope protein fragments in bacteria and use in seroepidemiological studies | Feb 13, 1994 | Issued |
Array
(
[id] => 3612556
[patent_doc_number] => 05510238
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-23
[patent_title] => 'Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies'
[patent_app_type] => 1
[patent_app_number] => 8/193510
[patent_app_country] => US
[patent_app_date] => 1994-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2127
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/510/05510238.pdf
[firstpage_image] =>[orig_patent_app_number] => 193510
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/193510 | Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies | Feb 6, 1994 | Issued |
Array
(
[id] => 3759046
[patent_doc_number] => 05851813
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Primate lentivirus antigenic compositions'
[patent_app_type] => 1
[patent_app_number] => 8/188583
[patent_app_country] => US
[patent_app_date] => 1994-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 67
[patent_no_of_words] => 18729
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/851/05851813.pdf
[firstpage_image] =>[orig_patent_app_number] => 188583
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/188583 | Primate lentivirus antigenic compositions | Jan 26, 1994 | Issued |
Array
(
[id] => 3690990
[patent_doc_number] => 05660828
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells'
[patent_app_type] => 1
[patent_app_number] => 8/177806
[patent_app_country] => US
[patent_app_date] => 1994-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4356
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/660/05660828.pdf
[firstpage_image] =>[orig_patent_app_number] => 177806
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/177806 | Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells | Jan 5, 1994 | Issued |
08/178461 | METHOD OF TREATING OR PREVENTING AUTOIMMUNE UVERORETINITIS IN MAMMALS | Jan 5, 1994 | Abandoned |
Array
(
[id] => 3700415
[patent_doc_number] => 05674720
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Design and construction of non-infectious human retroviral mutants deficient in genomic RNA'
[patent_app_type] => 1
[patent_app_number] => 8/176682
[patent_app_country] => US
[patent_app_date] => 1994-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8780
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674720.pdf
[firstpage_image] =>[orig_patent_app_number] => 176682
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/176682 | Design and construction of non-infectious human retroviral mutants deficient in genomic RNA | Jan 2, 1994 | Issued |
08/171858 | VACCINES BASED ON MEMBRANE BOUND PROTEINS AND PROCESS FOR MAKING THEM | Dec 20, 1993 | Abandoned |
Array
(
[id] => 3660260
[patent_doc_number] => 05591823
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-07
[patent_title] => 'Expression of specific immunogens using viral antigens'
[patent_app_type] => 1
[patent_app_number] => 8/169813
[patent_app_country] => US
[patent_app_date] => 1993-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8817
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/591/05591823.pdf
[firstpage_image] =>[orig_patent_app_number] => 169813
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/169813 | Expression of specific immunogens using viral antigens | Dec 16, 1993 | Issued |
Array
(
[id] => 3690701
[patent_doc_number] => 05691448
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-25
[patent_title] => 'Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome'
[patent_app_type] => 1
[patent_app_number] => 8/161290
[patent_app_country] => US
[patent_app_date] => 1993-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15667
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/691/05691448.pdf
[firstpage_image] =>[orig_patent_app_number] => 161290
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/161290 | Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome | Dec 1, 1993 | Issued |
Array
(
[id] => 3720265
[patent_doc_number] => 05681556
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Method and compositions for suppressing allograft rejection in mammals'
[patent_app_type] => 1
[patent_app_number] => 8/159044
[patent_app_country] => US
[patent_app_date] => 1993-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 7134
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681556.pdf
[firstpage_image] =>[orig_patent_app_number] => 159044
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/159044 | Method and compositions for suppressing allograft rejection in mammals | Nov 28, 1993 | Issued |
Array
(
[id] => 3623074
[patent_doc_number] => 05688914
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus'
[patent_app_type] => 1
[patent_app_number] => 8/150249
[patent_app_country] => US
[patent_app_date] => 1993-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8156
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688914.pdf
[firstpage_image] =>[orig_patent_app_number] => 150249
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/150249 | Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus | Nov 8, 1993 | Issued |
08/145664 | INDUCTION OF PROTECTION AGAINST VIRAL INFECTION BY SYNERGY BETWEEN VIRUS ENVELOPE GLYCOPROTEIN AND PEPTIDES CORRESPONDING TO NEUTRALIZATION EPITOPES OF THE GLYCOPROTEIN | Nov 3, 1993 | Abandoned |
08/143577 | INHIBITION OF HIV MUCOSAL BINDING | Oct 25, 1993 | Abandoned |
Array
(
[id] => 3993480
[patent_doc_number] => 05858366
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding'
[patent_app_type] => 1
[patent_app_number] => 8/135312
[patent_app_country] => US
[patent_app_date] => 1993-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11858
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858366.pdf
[firstpage_image] =>[orig_patent_app_number] => 135312
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/135312 | Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding | Oct 11, 1993 | Issued |